Glucose Reader Device Interaction Tracking for Metabolic Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing analyte monitoring systems face challenges in user adherence due to complexity, data volume, learning curve, and lack of actionable information, leading to suboptimal glucose monitoring in diabetic patients.
Innovation Solution
A glucose monitoring system with a sensor control device and reader device that includes wireless communication circuitry and processors to track user interaction frequency, providing notifications and improving user interface design for intuitive data access, thereby enhancing user engagement and metabolic parameter management.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If analyte monitoring systems provide comprehensive data collection and analysis capabilities, then measurement precision and reliability are improved, but device complexity and difficulty of operation increase
Solution Approach 1:
The patent introduces a processor as an intermediary component that receives raw analyte data from the sensor, processes it through algorithms, and generates simplified actionable insights. This mediator handles the complexity of data interpretation internally, presenting only essential information to the user through the display interface, thereby maintaining measurement precision while reducing operational complexity.
2Measurement precision
If analyte monitoring systems provide detailed data and comprehensive monitoring capabilities, then measurement precision is improved, but ease of operation deteriorates due to data volume and learning curve
Solution Approach 1:
The patent extracts and displays only the most critical and actionable information from the comprehensive analyte data set. Instead of presenting all raw data points, the system identifies and highlights key metrics such as current analyte levels, trend directions, and actionable recommendations, removing extraneous information that would complicate the user interface while preserving measurement precision.
Solution Approach 2:
The patent applies different levels of information presentation to different user needs and contexts. The interface provides simplified views for routine monitoring while offering more detailed data and analysis capabilities when users actively engage with specific features or when clinically indicated, allowing the system to adapt its complexity locally rather than uniformly.
3Measurement precision
If analyte monitoring systems provide extensive data collection, then measurement precision is improved, but loss of information occurs due to lack of actionable insights
Solution Approach 1:
The patent implements feedback mechanisms where the processor continuously analyzes analyte data patterns and provides actionable recommendations based on clinically validated algorithms. The system compares current readings against target ranges, identifies trends, and generates specific actionable insights such as when to adjust therapy or when to seek medical attention, ensuring that comprehensive data collection translates into practical guidance for users.
Data Source
AI summary
A glucose monitoring system includes a sensor control device comprising an analyte sensor coupled with sensor electronics, the sensor control device configured to transmit data indicative of an analyte level, and a reader device comprising a wireless communication circuitry configured to receive the data indicative of the analyte level, and one or more processors coupled with a memory. The memory is configured to store instructions that, when executed by the one or more processors, cause the one or more processors to: determine a frequency of interaction over a first time period based on one or more instances of user operation of the reader device, and output a first notification if the determined frequency of interaction is below a predetermined target level of interaction and output a second notification if the determined frequency of interaction is above the predetermined target level of interaction, wherein below the predetermined target level of interaction, an increase in the determined frequency of interaction corresponds to a first improvement in a metabolic parameter, and above the predetermined target level of interaction, an increase in the determined frequency of interaction corresponds to a second improvement in the metabolic parameter.